Sickle cell disease is the most common inherited blood disorder in the United States. New treatments are needed to prevent and treat its serious complications. That’s why the U.S. Food and Drug Administration is working with patients and stakeholders to help.
Be a Seed for Change 
You must be logged in to post a comment.